Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Menu

    Rilpivirine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,087Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Cabenuva

    02 1Complera

    03 1Complera /Eviplera

    04 8Complera/Eviplera

    05 11Edurant

    06 6Juluca

    07 8Odefsey

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Edurant

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Edurant

    U.S.A
    arrow
    PREP
    Not Confirmed

    Johnson & Johnson

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 964

    2019 Revenue in Millions : 861

    Growth (%) : 12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Juluca

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Juluca

    United Kingdom
    arrow
    PREP
    Not Confirmed

    GlaxoSmithKline

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 686

    2019 Revenue in Millions : 507

    Growth (%) : 35

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Odefsey

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    PREP
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,672

    2019 Revenue in Millions : 1,655

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Complera/Eviplera

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Complera/Eviplera

    U.S.A
    arrow
    PREP
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 269

    2019 Revenue in Millions : 406

    Growth (%) : -34

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Juluca

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Juluca

    United Kingdom
    arrow
    PREP
    Not Confirmed

    GlaxoSmithKline

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 700

    2020 Revenue in Millions : 678

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Edurant

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Edurant

    U.S.A
    arrow
    PREP
    Not Confirmed

    Johnson & Johnson

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 994

    2020 Revenue in Millions : 964

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Cabenuva

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Cabenuva

    United Kingdom
    arrow
    PREP
    Not Confirmed

    GlaxoSmithKline

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 51

    2020 Revenue in Millions : 0

    Growth (%) : New Launch in 2021

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Complera/Eviplera

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Complera/Eviplera

    U.S.A
    arrow
    PREP
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 258

    2020 Revenue in Millions : 269

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Odefsey

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    PREP
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 1,568

    2020 Revenue in Millions : 1,672

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Odefsey

    Cabotegravir, Rilpivirine

    arrow
    PREP
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    PREP
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 1,469

    2021 Revenue in Millions : 1,568

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF